ORMP · Company research
Oramed Pharmaceuticals Inc. (ORMP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A planned CFO sale at Oramed Pharmaceuticals (ORMP) totals 20,000 shares at an average $4.51. - Stock Titan | A planned CFO sale at Oramed Pharmaceuticals (ORMP) totals 20,000 shares at an average $4.51. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average. - Stock Titan | Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| An officer proposes selling 20,000 Oramed (ORMP) shares under a preset trading plan. - Stock Titan | An officer proposes selling 20,000 Oramed (ORMP) shares under a preset trading plan. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| 40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months. - Stock Titan | 40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Oramed Pharm Shareholders Back Governance and Incentive Plan - The Globe and Mail | Oramed Pharm Shareholders Back Governance and Incentive Plan The Globe and Mail | View source ↗ | The Globe and Mail | Sep 18, 2026 | neutral | 0 | 0.6 |
| Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP) - Seeking Alpha | Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 11, 2026 | neutral | 0 | 0.6 |
| Oramed Pharmaceuticals Inc (NASDAQ: ORMP) Share Price, ORMP Stock News, ORMP Share Price & Updates - Kalkine | Oramed Pharmaceuticals Inc (NASDAQ: ORMP) Share Price, ORMP Stock News, ORMP Share Price & Updates Kalkine | View source ↗ | Kalkine | Aug 13, 2026 | neutral | 0 | 0.6 |
| Oramed Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:ORMP - TradingView | Oramed Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:ORMP TradingView | View source ↗ | TradingView | Jul 25, 2026 | neutral | 0 | 0.6 |
| Oramed Pharmaceuticals Incorporated Actuals & Estimates (NASDAQ:ORMP) - TradingView | Oramed Pharmaceuticals Incorporated Actuals & Estimates (NASDAQ:ORMP) TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet - PR Newswire | Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet PR Newswire | View source ↗ | PR Newswire | Jun 25, 2026 | neutral | 0 | 0.6 |
| Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes - PR Newswire | Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes PR Newswire | View source ↗ | PR Newswire | Jun 17, 2026 | neutral | 0 | 0.6 |
| Oramed (ORMP) Set to Join Russell 2000 and 3000 Indexes in 2026 - GuruFocus | Oramed (ORMP) Set to Join Russell 2000 and 3000 Indexes in 2026 GuruFocus | View source ↗ | GuruFocus | Jun 17, 2026 | neutral | 0 | 0.6 |
| Oramed Pharmaceuticals: 'Hold' On Oral Insulin Drug Failure Pivot And New Strategic Investment Direction - Seeking Alpha | Oramed Pharmaceuticals: 'Hold' On Oral Insulin Drug Failure Pivot And New Strategic Investment Direction Seeking Alpha | View source ↗ | Seeking Alpha | May 22, 2026 | neutral | 0 | 0.6 |
| Oramed Pharmaceuticals' (NASDAQ:ORMP) Profits May Be Overstating Its True Earnings Potential - Simply Wall Street | Oramed Pharmaceuticals' (NASDAQ:ORMP) Profits May Be Overstating Its True Earnings Potential Simply Wall Street | View source ↗ | Simply Wall Street | Nov 21, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 6, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.